Skip to main content
Terug
Watch Compare

Outset Medical, Inc.

Datakwaliteit: 100%
OM
Nasdaq Manufacturing Measuring & Analyzing Instruments
€ 4,27
▲ € 0,07 (1,76%)
Marktkapitalisatie: 78,26 M
Prijs
€ 4,27
Marktkapitalisatie
78,26 M
Dagbereik
€ 4,08 — € 4,33
52-Weeksbereik
€ 3,00 — € 21,98
Volume
45.412
Openen € 4,16
50D / 200D Gem.
€ 3,88
10,06% above
50D / 200D Gem.
€ 9,81
56,44% below

Quick Summary

Belangrijkste Punten

Revenue grew 3,88% annually over 5 years — modest growth
Negative free cash flow of -47,13 M
Capital efficient — spends only 0,67% of revenue on capex

Groei

Revenue Growth (5Y)
3,88%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)5,09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-54,96%
Onder sectorgemiddelde (-53,41%)
ROIC-21,43%
Net Margin-68,34%
Op. Margin-55,83%

Veiligheid

Debt / Equity
0,67
Boven sectorgemiddelde (0,31)
Current Ratio7,09
Interest Coverage-4,78

Waardering

PE (TTM)
-0,96
Boven sectorgemiddelde (-1,48)
P/B Ratio0,55
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -1,0 -1,5
P/B 0,6 1,6
ROE % -55,0 -53,4
Net Margin % -68,3 -41,5
Rev Growth 5Y % 3,9 1,8
D/E 0,7 0,3

ETFs Holding This Stock

AVSC logo AVSC Avantis U.S. Small Cap Equity ETF
0,00% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 5,09% Revenue Growth (3Y) -4,27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 3,88% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 119,48 M Net Income (TTM) -81,65 M
ROE -54,96% ROA -28,85%
Gross Margin 39,13% Operating Margin -55,83%
Net Margin -68,34% Free Cash Flow (TTM) -47,13 M
ROIC -21,43% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,67 Current Ratio 7,09
Interest Coverage -4,78 Asset Turnover 0,42
Working Capital 227,92 M Tangible Book Value 142,37 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,96 Forward P/E N/A
P/B Ratio 0,55 P/S Ratio 0,66
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -60,22%
Market Cap 78,26 M Enterprise Value 137,35 M
Per Share
EPS (Diluted TTM) -5,37 Revenue / Share 6,53
FCF / Share -2,57 OCF / Share -2,53
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,67% FCF Conversion 57,71%
SBC-Adj. FCF -65,07 M Growth Momentum 1,21

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 119,48 M 113,69 M 130,38 M 115,38 M 102,60 M
Net Income -81,65 M -127,98 M -172,80 M -162,96 M -131,94 M
EPS (Diluted) -5,37 -2,46 -3,48 -3,38 —
Gross Profit 46,75 M 38,56 M 29,00 M 17,83 M 7,61 M
Operating Income -66,71 M -113,38 M -169,77 M -161,02 M -130,52 M
EBITDA — — — — —
R&D Expenses 21,24 M 38,40 M 57,31 M 48,86 M 36,74 M
SG&A Expenses — — — — —
D&A 4,34 M 5,73 M 5,81 M 5,17 M 5,16 M
Interest Expense 13,95 M 23,87 M 12,68 M 3,57 M 1,72 M
Income Tax 718.000,0 491.000,0 523.000,0 295.000,0 199.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 264,50 M 275,80 M 313,80 M 400,12 M 463,46 M
Total Liabilities 137,54 M 248,98 M 190,92 M 154,13 M 89,38 M
Shareholders' Equity 126,95 M 26,82 M 122,89 M 245,99 M 374,08 M
Total Debt 96,24 M 197,38 M 130,11 M 96,34 M 29,76 M
Cash & Equivalents 35,01 M 124,01 M 68,51 M 73,22 M 182,35 M
Current Assets 250,88 M 258,22 M 291,22 M 373,65 M 409,80 M
Current Liabilities 37,63 M 45,38 M 55,32 M 51,95 M 51,70 M